The DOI matches its Crossref record.
The IL Sequence in the LLKIL Motif in CXCR2 Is Required for Full Ligand-induced Activation of Erk, Akt, and Chemotaxis in HL60 Cells
Open accessAbstract
The chemotaxis of differentiated HL60 cells stably expressing CXCR2 was examined in a microfluidic gradient device where the steepness of the CXCL8 chemokine gradient was varied from 2 pg/ml/mum (0-1 ng/ml over a width of 500 microm) to 50 pg/ml/microm (0-25 ng/ml over 500 microm). The differentiated HL60 cells stably expressing CXCR2 exhibited little chemotaxis in response to a 0-1 ng/ml gradient, but displayed an increasing chemotactic response as the gradient steepness increased from 0 to 5, 0 to 10, and 0 to 25 ng/ml, demonstrating that steepness of gradient is a major determinant of the relative ability of cells to persistently migrate up a chemotactic gradient. When HL60 cells expressed CXCR2 mutated in the C terminus LLKIL motif (IL to AA), ligand-induced internalization of receptors was reduced 50%, whereas cell migration along the gradient of CXCL8 was completely lost. Although both mutant and wild-type receptors could mediate Akt and Erk activation in response to CXCL8, the level of activation of these two kinases was much lower in the cell line expressing the mutant receptors. These data imply that the IL amino acid residues in the LLKIL motif are very important for activation of the signal transduction cascade, which is necessary for cells to sense the chemokine gradient and respond with chemotaxis. Moreover, because mutation of the IL residues in the LLKIL motif resulted in only 50% reduction in receptor internalization, and a 50% reduction in Akt and Erk phosphorylation, but a complete loss of chemotactic response, the data imply that IL amino acid residues in the LLKIL motif are key either for amplification or oscillation of crucial signaling events or for establishment of a threshold for signals required for chemotaxis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CXCR2 localization in endosomes can be considered as a surrogate marker for CXCR2 activation.
“The location of CXCR2 in endosomes can be considered as a surrogate marker for CXCR2 activation (Sai et al., 2006”
From Chemokine signaling via the CXCR2 receptor reinforces senescence (2008) · cites this paper as Sai et al., 2006
The Results report rapid ligand-triggered CXCR2 internalization in HL60 cells, and the Discussion suggests a relationship between internalization and signaling. But the paper does not establish that CXCR2 specifically localizes to endosomes or that its endosomal location is a reliable surrogate marker of activation. The indexed passages provide no page numbers. (LLM, conf=0.78)
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 49
- Harris, 1954, Physiol. Rev., 34, 529, 10.1152/physrev.1954.34.3.529 · DOI
- Hersh, 1970, Annu. Rev. Med., 21, 105, 10.1146/annurev.me.21.020170.000541 · DOI
- Behar, 1994, J. Neurosci., 14, 29, 10.1523/JNEUROSCI.14-01-00029.1994 · DOI
- Muller, 2001, Nature, 410, 50, 10.1038/35065016 · DOI · Paper page
- Payne, 2002, J. Invest. Dermatol., 118, 915, 10.1046/j.1523-1747.2002.01725.x · DOI
- Chay, 2002, Urology, 60, 760, 10.1016/S0090-4295(02)01969-6 · DOI
- Cooper, 2003, Cancer, 97, 739, 10.1002/cncr.11181 · DOI
- Arai, 1997, J. Biol. Chem., 272, 25037, 10.1074/jbc.272.40.25037 · DOI
- Kim, 1997, J. Biol. Chem., 272, 27313, 10.1074/jbc.272.43.27313 · DOI
- Hsu, 1997, J. Biol. Chem., 272, 29426, 10.1074/jbc.272.47.29426 · DOI
- Kraft, 2001, J. Biol. Chem., 276, 34408, 10.1074/jbc.M102782200 · DOI
- Richardson, 2003, J. Immunol., 170, 2904, 10.4049/jimmunol.170.6.2904 · DOI
- Perez, 1989, J. Clin. Invest., 83, 1963, 10.1172/JCI114105 · DOI
- Samanta, 1990, J. Biol. Chem., 265, 183, 10.1016/S0021-9258(19)40213-5 · DOI
- Sambrano, 1999, J. Biol. Chem., 274, 20178, 10.1074/jbc.274.29.20178 · DOI
- Fernandis, 2002, J. Biol. Chem., 277, 18111, 10.1074/jbc.M200750200 · DOI
- Roland, 2003, Blood, 101, 399, 10.1182/blood-2002-03-0978 · DOI
- Fan, 2001, Biochemistry, 40, 791, 10.1021/bi001661b · DOI
- Sai, 2004, J. Cell Sci., 117, 5489, 10.1242/jcs.01398 · DOI
- Cheng, 2000, J. Biol. Chem., 275, 2479, 10.1074/jbc.275.4.2479 · DOI
- Collins, 1977, Nature, 270, 347, 10.1038/270347a0 · DOI
- Collins, 1978, Proc. Natl. Acad. Sci. U. S. A., 75, 2458, 10.1073/pnas.75.5.2458 · DOI
- Gallagher, 1985, Leuk. Res., 9, 967, 10.1016/0145-2126(85)90067-0 · DOI
- Bhalla, 1985, Cancer Res., 45, 3657
- Cross, 1997, Cytokine, 9, 521, 10.1006/cyto.1996.0196 · DOI
- Li Jeon, 2002, Nat. Biotechnol., 20, 826, 10.1038/nbt712 · DOI
- Lin, 2004, Biochem. Biophys. Res. Commun., 319, 576, 10.1016/j.bbrc.2004.05.029 · DOI
- Mueller, 1994, J. Biol. Chem., 269, 1973, 10.1016/S0021-9258(17)42123-5 · DOI
- Servant, 1999, Mol. Biol. Cell, 10, 1163, 10.1091/mbc.10.4.1163 · DOI
- Walker, 2005, Lab. Chip., 5, 611, 10.1039/b417245k · DOI
- Richardson, 1995, Biochemistry, 34, 14193, 10.1021/bi00043a025 · DOI
- Zigmond, 1977, J. Cell Biol., 75, 606, 10.1083/jcb.75.2.606 · DOI
- Parent, 1999, Science, 284, 765, 10.1126/science.284.5415.765 · DOI
- Firtel, 2000, BioEssays, 22, 603, 10.1002/1521-1878(200007)22:7<603::AID-BIES3>3.0.CO;2-# · DOI
- Servant, 2000, Science, 287, 1037, 10.1126/science.287.5455.1037 · DOI
- Xu, 2003, Cell, 114, 201, 10.1016/S0092-8674(03)00555-5 · DOI
- Knall, 1997, Proc. Natl. Acad. Sci. U. S. A., 94, 3052, 10.1073/pnas.94.7.3052 · DOI
- Fuhler, 2005, J. Leukoc. Biol., 77, 257, 10.1189/jlb.0504306 · DOI
- Fujita, 2005, Cell Signal, 17, 167, 10.1016/j.cellsig.2004.06.008 · DOI
- Jones, 1995, FEBS Lett., 364, 211, 10.1016/0014-5793(95)00397-R · DOI
- Van Lint, 1993, Mol. Cell Biochem., 127, 171, 10.1007/BF01076768 · DOI
- Grimes, 1973, Exp. Cell Res., 79, 375, 10.1016/0014-4827(73)90457-6 · DOI
- Ramsey, 1974, Exp. Cell Res., 86, 184, 10.1016/0014-4827(74)90669-7 · DOI
- Richardson, 1998, J. Biol. Chem., 273, 23830, 10.1074/jbc.273.37.23830 · DOI
- Rose, 2004, J. Biol. Chem., 279, 24372, 10.1074/jbc.M401364200 · DOI
- Luttrell, 1999, Science, 283, 655, 10.1126/science.283.5402.655 · DOI
- McDonald, 2000, Science, 290, 1574, 10.1126/science.290.5496.1574 · DOI
- Luttrell, 2001, Proc. Natl. Acad. Sci. U. S. A., 98, 2449, 10.1073/pnas.041604898 · DOI
- Su, 2005, J. Immunol., 175, 5396, 10.4049/jimmunol.175.8.5396 · DOI
Cited by
Sorted by citations
Chemokine signaling via the CXCR2 receptor reinforces senescence
Acosta, J. C., O'Loghlen, A., Banito, A., Guijarro, M. V., Augert, A., Raguz, S., Fumagalli, M., Da Costa, M., Brown, C., Popov, N., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.038 · Cited by 1,801
Metadata
- Authors
- Sai, J., Walker, G., Wikswo, J., & Richmond, A.
- Affiliations
- United States Department of Veterans Affairs (US)
- Vanderbilt University (US)
- Corresponding author
- Richmond, Ann
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-11
- Volume
- 281
- Issue
- 47
- Pages
- 35931-35941
- ISSN
- 0021-9258 (ISSN-L)
- PMC
- PMC2950015
- OpenAlex
- W2008761606
- Cited by
- 56
- References
- 0
- Citations by year
- 2025: 1 · 2024: 1 · 2023: 3 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 3 · 2016: 1 · 2015: 5 · 2014: 3 · 2013: 6 · 2012: 3
- FWCI
- 2.96
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Funders
- U.S. Department of Veterans Affairs (IK6 BX005225)
- Vanderbilt University (CA68485)
- National Institutes of Health (CA68485, CA34590)
- National Cancer Institute (CA 34590, U54CA113007, CA68485, R01CA034590, P50 CA113007, P30CA068485)
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- CXCR2, interleukin-8, chemokine gradients, chemotaxis, receptor internalization, ERK activation, Akt activation, signal transduction, HL-60 cells
- MeSH terms
- Cell Movement, Cell Separation, Chemotaxis, Enzyme Activation, Humans, Ligands, Mutation, Signal Transduction, Interleukin-8, Protein Structure, Tertiary, HL-60 Cells, Chemokines, GTP Phosphohydrolases, Amino Acid Motifs, Receptors, Interleukin-8B
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review